miRNA参与肿瘤基因表达调控研究进展

调查表明,我国城乡居民恶性肿瘤死亡率属于世界较高水平,而且呈持续的增长趋势。近年来的研究发现在肿瘤的发生与发展过程中涉及到多种因素,其中mi RNA可能扮演了重要的作用。mi RNA是一种长度约为22 nt的非编码短序列RNA,通过介导特异性的基因沉默导致靶m RNA降解,促使相应蛋白质的转译受阻而失去原有编码蛋白质的功能。mi RNA在细胞分裂周期中影响着基因的表达调控,在此过程中基因表达的失控就可能导致疾病的发生。而肿瘤的发生是以细胞恶变为基础,细胞恶变则是与细胞周期调控因素失衡相关,由此提示了一些mi RNA可能参与了肿瘤的发生、发展过程并在其中发挥了重要作用。随着研究的深入,mi RNA逐渐成为肿瘤诊治的新研究方向。本文主要讨论mi RNA在肿瘤基因表达调控方面的研究进展。     

植物逆境miRNA研究进展

包括生物和非生物在内的多种逆境胁迫是植物正常生长和作物产量提高的重要限制性因素。植物在长期的进化过程中, 通过诱导表达某些抵御或防卫途径的关键基因来实现对胁迫的响应。研究表明, 逆境胁迫不仅会诱导植物蛋白质编码基因的表达, 也会诱导一些非蛋白质编码基因的表达, 这类非蛋白质编码基因的表达产物在植物的生长、发育和应对逆境胁迫等过程中起到重要的调控作用。miRNA(小分子RNA)就是这类非蛋白质编码基因产物中的重要类群, 研究发现, 多种逆境均会诱导miRNA的产生, 其作用是通过引导目的基因mRNA的降解和阻止翻译过程来调控靶基因, 最终通过形态或生理上的变化达到对逆境的适应。文章主要对植物逆境胁迫下miRNA的研究, 特别是逆境胁迫诱导miRNA的产生、靶基因调控以及miRNA在植物适应逆境胁迫过程中的作用进行了综述, 同时, 文章还对在逆境胁迫下植物miRNA的研究方法进行了初步的探讨。     

内含子microRNA及其宿主基因的表达与功能

微小RNA(microRNAs,miRNAs)是一类具有转录后水平基因表达调控作用的非编码小分子RNA.microRNAs可参与机体发育、代谢及恶性肿瘤、心律失常等疾病的发生.近半数microRNA的编码基因位于已知编码蛋白基因的内含子中,称为"内含子microRNA",后者称为"宿主基因".由于内含子microRNA编码基因位置的特殊性,有研究者认为二者能够共同表达并发挥相似的生物学功能.它的发现不仅丰富了人们对内含子功能的认识,还有助于完善宿主基因功能的作用通路。     

应用双荧光报告系统检测斑马鱼microRNA的动态表达

microRNA(miRNA)是一类细胞内源表达的小分子非编码RNA, 主要通过降解靶基因的mRNA或者抑制靶基因的翻译, 在动植物的发育以及其他重要的生理过程中起调控作用。miRNA的功能跟它的表达位置与时间密切相关, 但是目前尚缺乏一个能够在活体与个体水平稳定、持续地实时观察miRNA动态表达的方法。文章以斑马鱼为模式, 建立了一个双荧光报告系统(我们称之为miRNA Tracer), 用于在斑马鱼整体胚胎中追踪特定miRNA的表达谱及动态变化过程。该系统以Tol2转座子为基础, 采用来自斑马鱼hsp70基因的热激启动子分别驱动eGFP和mRFP1荧光报告基因, 同时在其中一个报告基因的3′-UTR区连接待测miRNA的互补序列, 构成Tracer质粒。该互补序列与斑马鱼胚胎中相应的内源miRNA结合后能够使对应报告基因的荧光信号强度减弱, 通过比较两个报告基因在表达谱上的差异辨别miRNA的表达区域, 检测斑马鱼胚胎中miRNA起作用的位置和时间。文章选择在肌肉系统特异表达的miR-206以及在神经系统特异表达的miR-219, 分别在显微注射瞬时表达和转基因稳定整合等两个层次上验证了上述Tracer系统。结果表明, 所用的方法能够如实地在单细胞水平和整体水平检测到目标miRNA的时空表达动态变化。miRNA Tracer系统为在斑马鱼发育过程中对miRNA进行活体、实时的时空定位提供了一个独特而有效的方法, 也为对miRNA进行功能与作用机制等更深入的研究奠定了基础。

补充资料

s219mRFP1-dF转基因胚胎的3-D图像 [视频]     

microRNAs - powerful repression comes from small RNAs

microRNAs (miRNAs) encode a novel class of small, non-coding RNAs that regulate gene expression post-trancriptionally. miRNAs comprise one of the major non-coding RNA families, whose diverse biological functions and unusual capacity for gene regulation have attracted enormous interests in the RNA world. Over the past 16 years, genetic, biochemical and computational approaches have greatly shaped the growth of the field, leading to the identification of thousands of miRNA genes in nearly all metazoans. The key molecular machinery for miRNA biogenesis and silencing has been identified, yet the precise biochemical and regulatory mechanisms still remain elusive. However, recent findings have shed new light on how miRNAs are generated and how they function to repress gene expression. miRNAs provide a paradigm for endogenous small RNAs that mediate gene silencing at a genome-wide level. The gene silencing mediated by these small RNAs constitutes a major component of gene regulation during various developmental and physiological processes. The accumulating knowledge about their biogenesis and gene silencing mechanism will add a new dimension to our understanding about the complex gene regulatory networks.     

microRNAs as oncogenes and tumor suppressors

microRNAs (miRNAs) are a new class of non-protein-coding, endogenous, small RNAs. They are important regulatory molecules in animals and plants. miRNA regulates gene expression by translational repression, mRNA cleavage, and mRNA decay initiated by miRNA-guided rapid deadenylation. Recent studies show that some miRNAs regulate cell proliferation and apoptosis processes that are important in cancer formation. By using multiple molecular techniques, which include Northern blot analysis, real-time PCR, miRNA microarray, up- or down-expression of specific miRNAs, it was found that several miRNAs were directly involved in human cancers, including lung, breast, brain, liver, colon cancer, and leukemia. In addition, some miRNAs may function as oncogenes or tumor suppressors. More than 50% of miRNA genes are located in cancer-associated genomic regions or in fragile sites, suggesting that miRNAs may play a more important role in the pathogenesis of a limited range of human cancers than previously thought. Overexpressed miRNAs in cancers, such as mir-17-92, may function as oncogenes and promote cancer development by negatively regulating tumor suppressor genes and/or genes that control cell differentiation or apoptosis. Underexpressed miRNAs in cancers, such as let-7, function as tumor suppressor genes and may inhibit cancers by regulating oncogenes and/or genes that control cell differentiation or apoptosis. miRNA expression profiles may become useful biomarkers for cancer diagnostics. In addition, miRNA therapy could be a powerful tool for cancer prevention and therapeutics.